Cancer Genetics raises $15M in follow-on, moves to NASDAQ

Diagnostic company Cancer Genetics Inc. (NASDAQ:CGIX) raised $15 million late Tuesday through the sale of 1.5 million shares at $10 in a follow-on underwritten by Aegis and Feltl. Cancer Genetics also will start trading on NASDAQ on Wednesday. The company, which raised $6.9 million in an IPO on the OTC Bulletin Board in April, first announced plans to raise money in a follow-on and move to NASDAQ in June. Cancer Genetics was off $0.60 to $11.10 on Tuesday in its last day of trading on the OTC Bulletin Board. ...